Abiopharma

Sypris Reports Fourth Quarter Results

Firefly Confirms Public-Private Partnership with the Department of War

Jacobs secures role in one of Wisconsin’s largest interstate modernization programs

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

Isracard report regarding the execution of a 10-year agreement for the issuance of branded FLY CARD credit cards, details

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçets Disease

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

FORM 6-KBrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026